Table 3.

Standardized mortality ratios by times since hematopoietic cell transplantation

Disease categories	Observed events	SMR (95% CI)
All diagnoses, y from HCT
2 to 5; N = 307	192	54.8 (47.3-62.9)
6 to 10; N = 363	51	5.1 (3.8-6.6)
11 or more; N = 184	8	1.7 (0.7-3.0)
Standard risk of relapse, y from HCT
2 to 5; n = 163	86	37.8 (30.2-46.2)
6 to 10; n = 218	28	4.5 (2.9-6.3)
11 or more; n = 117	3	1.1 (0.2-2.8)
High risk of relapse, y from HCT
2 to 5; n = 143	105	85.8 (70.2-102.9)
6 to 10; n = 144	23	5.9 (3.8-8.7)
11 or more; n = 67	5	2.3 (0.7-4.8)
Acute myeloid leukemia, y from HCT
2 to 5; n = 39	16	27.0 (15.4-41.9)
6 to 10; n = 74	7	3.4 (1.4-6.5)
11 or more; n = 45	1	0.9 (0-3.7)
Non-Hodgkin lymphoma, y from HCT
2 to 5; n = 145	84	34.9 (27.8-42.7)
6 to 10; n = 181	25	3.9 (2.5-5.6)
11 or more; n = 66	4	1.6 (0.4-3.6)
Hodgkin disease, y from HCT
2 to 5; n = 102	73	151.1 (118.5-187.8)
6 to 10; n = 98	15	10.2 (5.7-16.0)
11 or more; n = 45	2	1.9 (0.2-5.5)
Acute lymphoblastic leukemia, y from HCT
2 to 5; n = 21	19	1004.0 (603.3-1506.2)
6 to 10; n = 10	4	26.5 (6.9-58.9)
11 or more; n = 28	1	4.2 (0.0-16.6)